[Synthesis of certain derivatives of amphetamine]. 1953

S BINIECKI, and E MUSZYNSKI

UI MeSH Term Description Entries
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Related Publications

S BINIECKI, and E MUSZYNSKI
January 1996, Pharmacology, biochemistry, and behavior,
S BINIECKI, and E MUSZYNSKI
July 1949, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
S BINIECKI, and E MUSZYNSKI
July 1946, Journal of the American Chemical Society,
S BINIECKI, and E MUSZYNSKI
July 1946, Journal of the American Chemical Society,
S BINIECKI, and E MUSZYNSKI
February 1951, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
S BINIECKI, and E MUSZYNSKI
July 2001, Journal of medicinal chemistry,
S BINIECKI, and E MUSZYNSKI
May 1996, Bollettino chimico farmaceutico,
S BINIECKI, and E MUSZYNSKI
June 2005, Bioorganic & medicinal chemistry,
S BINIECKI, and E MUSZYNSKI
June 2009, Acta pharmaceutica (Zagreb, Croatia),
S BINIECKI, and E MUSZYNSKI
March 1951, Doklady Akademii nauk SSSR,
Copied contents to your clipboard!